ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.590
-0.020 (-1.24%)
At close: May 12, 2025, 4:00 PM
1.590
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $167.29 million as of May 12, 2025. Its market cap has increased by 2.32% in one year.
Market Cap
167.29M
Enterprise Value
42.38M
1-Year Change
2.32%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has decreased from $308.80M to $167.29M, a decrease of -45.83%. That is a compound annual growth rate of -5.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 173.40M | -22.35% |
Dec 31, 2024 | 223.30M | 33.87% |
Dec 29, 2023 | 166.80M | -39.78% |
Dec 30, 2022 | 277.00M | -53.81% |
Dec 31, 2021 | 599.70M | 164.07% |
Dec 31, 2020 | 227.10M | -46.89% |
Dec 31, 2019 | 427.60M | -15.11% |
Dec 31, 2018 | 503.70M | 568.92% |
Dec 29, 2017 | 75.30M | -34.18% |
Dec 30, 2016 | 114.40M | -43.53% |
Dec 31, 2015 | 202.60M | -55.40% |
Dec 31, 2014 | 454.30M | 47.12% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.55B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |